Link Says Versant’s Eyes Will Be On Ophthalmology
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 002″]
Bill Link explains why ophthalmology will continue to be a pillar for Versant’s new fund. He also talks about the impact of industry consolidation, the Sunshine Act, and he offers helpful advice to entrepreneurs and physicians looking to turn inspiration into innovation.
Podcast Guest
William J. Link, PhD
Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986. Bill served on the Board of AMO’s successor company, Advanced Medical Optics (acquired by Abbott in 2009).
